PCO371

PCO371
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T16442-1mg 1 mg

7 - 10 business days*

97.00€
TGM-T16442-5mg 5 mg

7 - 10 business days*

245.00€
TGM-T16442-1mL 1 ml

7 - 10 business days*

345.00€
TGM-T16442-10mg 10 mg

7 - 10 business days*

395.00€
TGM-T16442-25mg 25 mg

7 - 10 business days*

660.00€
TGM-T16442-50mg 50 mg

7 - 10 business days*

944.00€
TGM-T16442-100mg 100 mg

7 - 10 business days*

1,281.00€
 
Description: PCO371 (2,4-Imidazolidinedione,... more
Product information "PCO371"
Description: PCO371 (2,4-Imidazolidinedione, 1-(3,5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl)-1,3,8-triazaspiro(4.5)dec-1-en-8-yl)sulfonyl)ethyl)phenyl)-5,5-dimethyl-) is an orally active full agonist of parathyroid hormone receptor 1. It has no effect on PTH type 2 receptor. Target: Thyroid hormone receptor(THR). Smiles: Cc1cc(cc(C)c1CCS(=O)(=O)N1CCC2(CC1)N=C(NC2=O)c1ccc(OC(F)(F)F)cc1)N1C(=O)NC(=O)C1(C)C. References: Tamura T, et al. Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism. Nat Commun. 2016 Nov 18,7:13384.
Keywords: 2,4-Imidazolidinedione, 1-(3,5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl)-1,3,8-triazaspiro(4.5)dec-1-en-8-yl)sulfonyl)ethyl)phenyl)-5,5-dimethyl-
Supplier: TargetMol
Supplier-Nr: T16442

Properties

Application: PTH1R agonist
MW: 635.65 D
Formula: C29H32F3N5O6S

Database Information

CAS : 1613373-33-3| Matching products
KEGG ID : K04585 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "PCO371"
Write a review
or to review a product.
Viewed